
Invitae Corporation NVTA
Quartalsbericht 2023-Q3
hinzugefügt 08.11.2023
Invitae Corporation EBITDA per Share 2011-2026 | NVTA
EBITDA per Share Jährlich Invitae Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.2 | -0.64 | -4.56 | -2.51 | -1.63 | -2.41 | -2.82 | -2.98 | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 0.2 | -4.56 | -2.17 |
EBITDA per Share Vierteljährlich Invitae Corporation
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -3.54 | -0.84 | -0.56 | - | -1.18 | -10.8 | -0.81 | -0.94 | -0.62 | 0.8 | -0.49 | -1.78 | -0.44 | -0.99 | -0.92 | -0.8 | -0.69 | -0.5 | -0.41 | -0.34 | -0.28 | -0.34 | -0.61 | -0.65 | -0.52 | -0.57 | -0.61 | -0.61 | -0.62 | -0.67 | -0.75 | -0.76 | -0.59 | -0.69 | -1.03 | -16.2 | -12.4 | -11.6 | -11.4 | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 0.8 | -16.2 | -2.28 |
EBITDA per Share anderer Aktien in der Diagnostik & Forschung
| Name | EBITDA per Share | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-0.94 | - | -6.23 % | $ 30.6 M | ||
|
Castle Biosciences
CSTL
|
-0.07 | $ 20.41 | 1.9 % | $ 592 M | ||
|
Fulgent Genetics
FLGT
|
-1.62 | $ 17.34 | 5.67 % | $ 524 M | ||
|
Guardant Health
GH
|
-3.17 | $ 118.55 | 3.11 % | $ 14.9 B | ||
|
ICON Public Limited Company
ICLR
|
19.2 | $ 115.14 | 0.04 % | $ 9.5 B | ||
|
Illumina
ILMN
|
-3.01 | $ 144.35 | 1.71 % | $ 23 B | ||
|
Agilent Technologies
A
|
5.49 | $ 113.97 | 0.21 % | $ 34.6 B | ||
|
Celcuity
CELC
|
-3.68 | $ 141.62 | 0.91 % | $ 6.62 B | ||
|
Co-Diagnostics
CODX
|
-36.9 | $ 3.88 | 62.44 % | $ 5.16 M | ||
|
Akumin
AKU
|
0.78 | - | -17.87 % | $ 25.9 M | ||
|
Aspira Women's Health
AWH
|
-0.23 | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
-0.15 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
-1.79 | - | -13.05 % | $ 7.29 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
0.00122 | - | - | $ 562 M | ||
|
CareDx, Inc
CDNA
|
-0.3 | $ 21.66 | 2.39 % | $ 1.15 B | ||
|
Chembio Diagnostics
CEMI
|
-0.65 | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
-0.38 | - | - | $ 9.42 M | ||
|
HTG Molecular Diagnostics
HTGM
|
-22.8 | - | -20.0 % | $ 1.06 M | ||
|
Lantheus Holdings
LNTH
|
5.64 | $ 94.6 | -1.56 % | $ 6.38 B | ||
|
Interpace Biosciences
IDXG
|
1.02 | $ 1.8 | - | $ 7.96 M | ||
|
Medpace Holdings
MEDP
|
19.5 | $ 424.51 | 0.63 % | $ 12.2 B | ||
|
Mettler-Toledo International
MTD
|
2.48 | $ 1 086.52 | 0.31 % | $ 22.4 B | ||
|
Global Cord Blood Corporation
CO
|
5.37 | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
-1.27 | - | - | $ 7.1 B | ||
|
Natera
NTRA
|
-5.33 | $ 204.45 | -0.23 % | $ 20.1 B | ||
|
Genetron Holdings Limited
GTH
|
-1.12 | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
-3.17 | - | -11.32 % | $ 2.94 M | ||
|
Personalis
PSNL
|
-0.87 | $ 8.3 | 4.4 % | $ 741 M | ||
|
Charles River Laboratories International
CRL
|
8.64 | $ 159.56 | 2.22 % | $ 7.91 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
8.68 | - | - | $ 10.7 B | ||
|
Enzo Biochem
ENZ
|
-218 | - | -8.98 % | $ 14.8 K | ||
|
NeoGenomics
NEO
|
-0.62 | $ 8.96 | 0.67 % | $ 1.15 B | ||
|
Exact Sciences Corporation
EXAS
|
-0.43 | - | - | $ 19.8 B | ||
|
National Research Corporation
NRC
|
1.35 | $ 19.06 | -1.04 % | $ 427 M | ||
|
Myriad Genetics
MYGN
|
-3.6 | $ 3.81 | -0.13 % | $ 353 M | ||
|
Thermo Fisher Scientific
TMO
|
23.3 | $ 448.97 | -0.59 % | $ 169 B | ||
|
Heska Corporation
HSKA
|
-0.61 | - | - | $ 1.31 B | ||
|
Koninklijke Philips N.V.
PHG
|
2.69 | $ 27.16 | 1.61 % | $ 25.8 B | ||
|
Twist Bioscience Corporation
TWST
|
-1.86 | $ 55.04 | 2.57 % | $ 3.29 B | ||
|
Senseonics Holdings
SENS
|
-1.6 | $ 5.96 | 4.38 % | $ 249 M | ||
|
QIAGEN N.V.
QGEN
|
3.04 | - | - | $ 10.6 B | ||
|
Soleno Therapeutics
SLNO
|
0.22 | - | - | $ 2.69 B | ||
|
Biomerica
BMRA
|
-2.2 | $ 2.41 | 2.55 % | $ 5.54 M | ||
|
Waters Corporation
WAT
|
6.02 | $ 339.58 | -0.48 % | $ 20.2 B | ||
|
Laboratory Corporation of America Holdings
LH
|
24.8 | $ 254.26 | -1.19 % | $ 21.2 B | ||
|
Trinity Biotech plc
TRIB
|
-0.06 | $ 0.62 | 2.96 % | $ 223 M | ||
|
Motus GI Holdings
MOTS
|
-7.41 | - | -34.28 % | $ 263 K | ||
|
Exagen
XGN
|
-0.56 | $ 4.06 | 6.01 % | $ 87.5 M | ||
|
Neogen Corporation
NEOG
|
-4.34 | $ 8.77 | -0.68 % | $ 1.9 B |